Russia begins production of first registered Covid vaccine Sputnik V

Published On 2020-08-17 07:12 GMT   |   Update On 2020-08-17 07:12 GMT
Advertisement

MoscowRussia has begun production of the first batch of vaccines against COVID-19, its health ministry said in a statement released on Saturday.

Russian President Vladimir Putin on Tuesday announced the world's first registered vaccine against the novel coronavirus, Sputnik V, which is named after the space satellite launched by Moscow in 1957.
The vaccine was created by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, a medical institute located near Moscow, Xinhua news agency reported.
Advertisement
Russia will offer the vaccine to other countries once its own citizens are vaccinated, Health Minister Mikhail Murashko said Wednesday, adding that doubts over the effectiveness of the vaccine are unfounded.
So far, Russia has tallied a total of 917,884 cases, with 15,617 deaths and 729,411 recoveries.

Tags:    
Article Source : IANS

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News